The Effect of Omalizumab on Airway Responsiveness to Adenosine in Patients With Poorly Controlled Asthma

Part of paid clinical trials in Gainesville, Florida.

Sponsor
University of Florida
Study ID
NCT00133042
Phase
PHASE4
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
6 Years - 26 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of this study is to determine whether the addition of omalizumab in patients with poorly controlled asthma (because of poor adherence) will decrease allergic airway inflammation and improve asthma control.

Key Dates

Start date
Dec 31, 2004
Status verified
Feb 2009
Primary completion
Dec 31, 2006
Completion
Dec 31, 2006

Study Design

Enrollment
16 participants
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT

Primary Outcome Measure

adenosine, PC20, forced expiratory volume in one second (FEV1)

Locations (1)

FacilityCityStateZIPSite coordinators
University of Florida Asthma Research LabGainesvilleFlorida32610-

Find similar trials in Gainesville, FL

By condition
Asthma
By specialty
PulmonologyLung disease
By research site
University of Florida Asthma Research Lab· Gainesville, FL

Related Studies